Pure ductal carcinoma in situ: kinetic and morphologic MR characteristics compared with mammographic appearance and nuclear grade.
about
MRI screening for breast cancer in women at high risk; is the Australian breast MRI screening access program addressing the needs of women at high risk of breast cancer?High-spatial- and high-temporal-resolution dynamic contrast-enhanced MR breast imaging with sweep imaging with Fourier transformation: a pilot study.Imaging studies for the early detection of breast cancerFeatures of occult invasion in biopsy-proven DCIS at breast MRI.Cancerous breast lesions on dynamic contrast-enhanced MR images: computerized characterization for image-based prognostic markers.Relationship of temporal resolution to diagnostic performance for dynamic contrast enhanced MRI of the breastKinetic curves of malignant lesions are not consistent across MRI systems: need for improved standardization of breast dynamic contrast-enhanced MRI acquisition.Characterization of Pure Ductal Carcinoma In Situ on Dynamic Contrast-Enhanced MR Imaging: Do Nonhigh Grade and High Grade Show Different Imaging Features?Detection of in situ mammary cancer in a transgenic mouse model: in vitro and in vivo MRI studies demonstrate histopathologic correlation.The diverse pathology and kinetics of mass, nonmass, and focus enhancement on MR imaging of the breast.Differentiation between benign and malignant breast lesions detected by bilateral dynamic contrast-enhanced MRI: a sensitivity and specificity study.Semi-quantitative parameter analysis of DCE-MRI revisited: monte-carlo simulation, clinical comparisons, and clinical validation of measurement errors in patients with type 2 neurofibromatosis.Accuracy of 3 T versus 1.5 T breast MRI for pre-operative assessment of extent of disease in newly diagnosed DCIS.Dynamic contrast-enhanced MR microscopy identifies regions of therapeutic response in a preclinical model of colorectal adenocarcinoma.In vivo assessment of ductal carcinoma in situ grade: a model incorporating dynamic contrast-enhanced and diffusion-weighted breast MR imaging parameters.Can MRI biomarkers at 3 T identify low-risk ductal carcinoma in situ?Differentiation of ductal carcinoma in-situ from benign micro-calcifications by dedicated breast computed tomographyMRI in the differential diagnosis of primary architectural distortion detected by mammographyBreast ductal carcinoma in situ: morphologic and kinetic MRI findings.DCEMRI of breast lesions: is kinetic analysis equally effective for both mass and nonmass-like enhancement?Ductal carcinoma in situ: X-ray fluorescence microscopy and dynamic contrast-enhanced MR imaging reveals gadolinium uptake within neoplastic mammary ducts in a murine model.Magnetic resonance imaging in the evaluation of ductal carcinoma in situ.Normal parenchymal enhancement patterns in women undergoing MR screening of the breast.Detection of invasive components in cases of breast ductal carcinoma in situ on biopsy by using apparent diffusion coefficient MR parameters.A new approach to analysis of the impulse response function (IRF) in dynamic contrast-enhanced MRI (DCEMRI): a simulation study.The role of breast MR imaging in pre-operative determination of invasive disease for ductal carcinoma in situ diagnosed by needle biopsy.The diagnostic sensitivity of dynamic contrast-enhanced magnetic resonance imaging and breast-specific gamma imaging in women with calcified and non-calcified DCIS.MR imaging appearance of noncalcified and calcified DCIS.Contrast enhancement kinetics of normal breast parenchyma in dynamic MR mammography: effects of menopausal status, oral contraceptives, and postmenopausal hormone therapy.Ductal carcinoma in situ of the breast: Evaluation of main presentations on magnetic resonance imaging compared with findings on mammogram and histology.Role of preoperative breast MRI in ductal carcinoma in situ for prediction of the presence and assessment of the extent of occult invasive component.
P2860
Q26785571-5497A489-9609-4D63-9C0D-B4D5C874EB00Q30392540-DF1193C1-930C-4AA9-A6C2-6999EE76F7F0Q33480984-3F5503FA-0175-46A1-A368-358F7CB94801Q33677927-189A45DC-6E7C-4E28-A33E-905CB6741D1EQ33679786-901771BD-5AAF-400F-A11A-A8E3B1ADC45FQ34109742-32691C79-46EA-4CD9-862A-0E380A9C87E9Q34124726-A5FB0A5E-F49E-46E3-A1BD-00766C6C97D4Q34159460-35496953-D4D7-44B7-AFF6-DB5C1E24987FQ34610869-A9EDBF11-D224-4FE9-BA40-759437C708B1Q34993938-E1791D5D-E10B-4ED9-A75A-A626827CF4DEQ35062357-58112462-2225-479E-BE96-740861B05698Q35110740-F7BB5C1A-6446-42E9-AF10-212FC2042B1FQ35142869-26E03E62-3307-4366-9D16-EA8E9527A598Q35537599-B6E34352-0A48-4F2A-9C34-4F19C41F8EF0Q35896750-507F2C40-A3D1-4438-9DFA-4E2674F4E5A6Q36395910-BFD9C7EB-3FE5-4671-9A92-8AC910BA7894Q36422251-9AA381E6-FB0E-4A4F-AD6C-7F115F295159Q36682742-1E559B1B-A515-4E3A-89DC-D0F6CD16C11EQ37156041-6C30B715-56A6-44FE-999B-59A710C01DD0Q37170158-353A882A-B54E-4A1E-8A3A-E450FF8087C1Q37404908-7BF772E7-ABA2-4D69-9850-54599D300669Q37509620-566A77DA-91A5-40DE-B866-F6A0879025EEQ37843817-DA168EAE-D402-402A-B585-AA70191670E6Q38111637-F0738CF0-FBD4-4A01-B15F-4EDEF6B51217Q42486451-A93926F3-F9AC-4ADA-A9C4-5553DF970F83Q44112416-287DCF4B-5977-4BFF-95EA-FF3103D77422Q46962371-5A600584-AFFD-4EBD-95F4-4C6095FF80C7Q48301233-4321A715-3C9C-4994-A3EF-8F6C323DB4CFQ51326990-706C4177-76E3-4378-BFBA-98E96D607376Q52971222-16FEF1FD-AF16-4CE0-B2A4-368E18FBFC8AQ54748657-C9F293E9-8CB2-4D76-A23E-C87211B2F922
P2860
Pure ductal carcinoma in situ: kinetic and morphologic MR characteristics compared with mammographic appearance and nuclear grade.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on December 2007
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Pure ductal carcinoma in situ: ...... appearance and nuclear grade.
@en
Pure ductal carcinoma in situ: ...... appearance and nuclear grade.
@nl
type
label
Pure ductal carcinoma in situ: ...... appearance and nuclear grade.
@en
Pure ductal carcinoma in situ: ...... appearance and nuclear grade.
@nl
prefLabel
Pure ductal carcinoma in situ: ...... appearance and nuclear grade.
@en
Pure ductal carcinoma in situ: ...... appearance and nuclear grade.
@nl
P2093
P1433
P1476
Pure ductal carcinoma in situ: ...... appearance and nuclear grade.
@en
P2093
Akiko Shimauchi
Gillian M Newstead
Gregory S Karczmar
Hiroyuki Abe
Robert A Schmidt
Sanaz A Jansen
P304
P356
10.1148/RADIOL.2453062061
P407
P577
2007-12-01T00:00:00Z